CHAMPIONS ONCOLOGY, INC.

CSBR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
254
SEC Filings

Business Summary

PART I Overview We are a technology-enabled research organization engaged in creating technology solutions to be utilized in drug discovery and development. Our research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Our pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. At the core of our research pl...

Next Earnings

Q2 FY2026 — expected 2026-09-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCSBRdiscussed_in_filing Artificial Intelligence
topic_mentionCSBRdiscussed_in_filing Data Center
topic_mentionCSBRdiscussed_in_filing Cloud Computing
topic_mentionCSBRdiscussed_in_filing Cybersecurity
topic_mentionCSBRdiscussed_in_filing Trusted Computing
topic_mentionCSBRdiscussed_in_filing Blockchain & Crypto
topic_mentionCSBRdiscussed_in_filing Regulation
topic_mentionCSBRdiscussed_in_filing Enterprise
topic_mentionCSBRdiscussed_in_filing Healthcare & Bio
topic_mentionCSBRdiscussed_in_filing AI Compute
topic_mentionCSBRdiscussed_in_filing Platform & Ecosystem
topic_mentionCSBRdiscussed_in_filing Sovereign & Government
topic_mentionCSBRdiscussed_in_filing Artificial Intelligence
topic_mentionCSBRdiscussed_in_filing Data Center
topic_mentionCSBRdiscussed_in_filing Cloud Computing
topic_mentionCSBRdiscussed_in_filing Cybersecurity
topic_mentionCSBRdiscussed_in_filing Trusted Computing
topic_mentionCSBRdiscussed_in_filing Blockchain & Crypto
topic_mentionCSBRdiscussed_in_filing Regulation
topic_mentionCSBRdiscussed_in_filing Enterprise

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-07-232025-04-300001628280-25-035765EDGAR29K words
2024-07-192024-04-300001628280-24-032321EDGAR
2023-07-242023-04-300001628280-23-025464EDGAR
2022-07-222022-04-300001628280-22-019309EDGAR
2021-07-262021-04-300001628280-21-014464EDGAR
2020-07-282020-04-300001628280-20-010734EDGAR
2019-07-292019-04-300001628280-19-009139EDGAR
2018-07-302018-04-300001628280-18-009773EDGAR
2017-07-282017-04-300001628280-17-007429EDGAR
2016-07-292016-04-300001628280-16-017936EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-03-122026-01-310001628280-26-017345EDGAR14K words
2025-12-152025-10-310001628280-25-057082EDGAR
2025-09-152025-07-310000771856-25-000023EDGAR
2025-03-172025-01-310001628280-25-012941EDGAR
2024-12-162024-10-310001628280-24-051389EDGAR
2024-09-132024-07-310001628280-24-040312EDGAR
2024-03-152024-01-310001628280-24-011279EDGAR
2023-12-132023-10-310001628280-23-041457EDGAR
2023-09-132023-07-310001628280-23-032212EDGAR
2023-03-162023-01-310001628280-23-008251EDGAR
2022-12-132022-10-310001628280-22-031818EDGAR
2022-09-122022-07-310001628280-22-024751EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001628280-26-021941EDGAR1K words
2026-03-120001628280-26-017259EDGAR
2025-12-150001628280-25-057020EDGAR
2025-10-160001628280-25-045241EDGAR
2025-09-150000771856-25-000022EDGAR
2025-07-230001628280-25-035727EDGAR
2025-07-210001628280-25-035424EDGAR
2025-03-110001628280-25-012022EDGAR
2024-12-110001628280-24-050789EDGAR
2024-10-150001628280-24-042780EDGAR

254 total filings indexed. 222 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0000771856
TickerCSBR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 804d4d0c4337c18b8b575bcf32b453f31052f90907c4d3eca6299648fe834d3c
parent: 2cfd0a2322ec7186819c37a8ed737a5a3bd02b9ace231af44c41408c71ae99e6
content hash: 95f2fe6af8597e2f766d9fa140da7d791decc1996f69dc6008619e2581751956
signed: 2026-04-13T04:44:30.976Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf